Procter & Gamble (PG) Stock Gains as Q3 Earnings Clear the Bar on All Fronts

TLDR

• P&G reported Q3 fiscal 2026 EPS of $1.59 adjusted, beating the $1.56 estimate
• Revenue came in at $21.24 billion, topping Wall Street’s $20.5 billion forecast
• Volume grew 2% year-on-year — the first positive volume reading in a year
• Beauty division led the way with 5% volume growth; grooming and health care lagged
• Full-year guidance was reiterated, with EPS growth projected at 1%–6%

Procter & Gamble posted a solid fiscal third quarter on Friday, beating both earnings and revenue estimates. The stock rose around 4% in premarket trading following the results.

The Procter & Gamble Company, PG

The company reported adjusted EPS of $1.59, ahead of the $1.56 analysts expected. Revenue came in at $21.24 billion, up 7% year-on-year and well above the $20.5 billion consensus estimate.

Organic sales, which strip out currency moves, acquisitions and divestitures, rose 3%.

One of the cleaner wins in the report was volume. P&G posted 2% volume growth for the quarter — the first time in a year the company has grown volume across the whole business.

Volume matters more than headline sales for a company like P&G. It strips out pricing effects and gives a cleaner read on actual demand.

CFO Andre Schulten described the U.S. consumer as “stable,” while noting that bifurcation between consumer segments is continuing. That’s a polite way of saying lower-income shoppers are still under pressure.

The beauty segment — home to Olay, Head & Shoulders and Pantene — was the standout. It posted 5% volume growth, with gains across personal care, skin care and hair care.

Baby, feminine and family care followed with 3% volume growth, driven by stronger demand for diapers and family care products including Bounty and Charmin.

Fabric and home care, which includes Tide, grew volume 2%, helped by North American demand.

Where It Struggled

Not every segment kept pace. Grooming — which includes Gillette and Venus — saw volume fall 2%. Health care, covering Oral-B and Vicks, also dropped 2%.

Operating margin came in at 21.5%, down from 23.3% in the same period last year. Gross margin also missed analyst expectations, a point worth watching.

What’s Ahead

P&G reiterated its full-year outlook. The company is guiding for sales growth of 1%–5% and net EPS growth of 1%–6%, with full-year adjusted EPS guidance at $6.96 at the midpoint.

CEO Shailesh Jejurikar said the company is increasing investment to build consumer momentum despite a challenging economic backdrop.

One headwind flagged for Q4: a projected $150 million cost increase, driven largely by higher transportation costs tied to rising fuel prices.

Free cash flow margin held steady at 14.3%, roughly in line with the same period last year.

The stock was trading up approximately 2.6% to $149.47 shortly after the report, before extending gains to around 4% in premarket.

The post Procter & Gamble (PG) Stock Gains as Q3 Earnings Clear the Bar on All Fronts appeared first on CoinCentral.